Results 161 to 170 of about 102,615,988 (206)

Plant-Derived Agents and Systemic Sclerosis: A Systematic Review of Therapeutic Potential and Molecular Mechanisms. [PDF]

Curr Issues Mol Biol
Ilie CM, Grădinaru TC, Boromiz CA, Gilca M.   +3 more
europepmc   +1 more source

Effects of <i>Withania somnifera (L.) Dunal</i> (Ashwagandha) on cognitive and physical function in adults: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Zhu X, Zeng Q, Lei Y, Xu D.
europepmc   +1 more source

Ashwagandha (<i>Withania somnifera</i>) Plant Extracts Affect the Cytochrome P450 System and Cytotoxicity of Primary Human Hepatocytes. [PDF]

J Diet Suppl
McDonald KL, Raichura Z, Pondugula SR, Marney L, Yang L, Choi J, Salamat JM, Brandes MS, Neff C, Adams K, Farmer G, Dennis C, Maier CS, Soumyanath A, Arnold RD, Calderón AI.   +15 more
europepmc   +1 more source

Preclinical Evidence of <i>Withania somnifera</i> and <i>Cordyceps</i> spp.: Neuroprotective Properties for the Management of Alzheimer's Disease. [PDF]

Int J Mol Sci
Tancreda G, Tancreda G, Ravera S, Panfoli I.   +3 more
europepmc   +1 more source

Pharmacological Insights Into Ashwagandha (Withania somnifera): A Review of Its Immunomodulatory and Neuroprotective Properties. [PDF]

Cureus
Dipankar SP, Dani MM, Anirudhan R, Tripathi D, Mishra C, Devi SH.   +5 more
europepmc   +1 more source

Natural Products Targeting BCR-ABL: A Plant-Based Approach to Chronic Myeloid Leukemia Treatment. [PDF]

Molecules
Pechlivani L, Giannakis A, Sioka C, Alexiou GA, Kyritsis AP.   +4 more
europepmc   +1 more source

Withaferin A inhibits EBV-driven lymphomagenesis through multiple mechanisms, including EBNA1 degradation.

Blood
Stewart J, Damania B.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cytotoxic screening and antibacterial activity of Withaferin A

Journal of Toxicology and Environmental Health, Part A, 2022
Cancer and bacterial infections are among the leading causes of death worldwide. Plant-derived bioactive compounds constitute promising alternatives for development of new therapeutics. This study aimed at evaluating the biological activity of Withaferin A using 6 tumor cell lines: A549 (lung cancer), U87MG (glioblastoma), SH-SY5Y (neuroblastoma), B16 ...
Altevir, Rossato Viana, B, Godoy Noro, J C, Lenz, M, Luiza Machado Teixeira, M, Bolson Serafin, R, Hörner, C, Franco, L, Maria Fontanari Krause, B, Stefanello Vizzotto, B, Jalfim Maraschin   +9 more
openaire   +2 more sources

Withaferin A: From Ancient Remedy to Potential Drug Candidate [PDF]

Molecules, 2021
Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda.
Ihsan-Ul Haq, Hamada Abdelgawad, Mohammad K Okla   +2 more
exaly   +5 more sources

Microbiological and chemical dehydrogenation of withaferin A

Folia Microbiologica, 1987
Arthrobacter simplex dehydrogenated withaferin A to 4-dehydrowithaferin A but it was not able to dehydrogenate this substrate in position 27. 27-Dehydrowithaferin A was prepared chemically using pyridinium chlorochromate. Whereas 4-dehydrowithaferin A surpassed in its effect on leukemic (388 cells the original compound and all its derivates synthesized
J, Fuska, B, Proska, J, Williamson, J P, Rosazza   +3 more
openaire   +2 more sources